000 01754 a2200505 4500
005 20250516031532.0
264 0 _c20110704
008 201107s 0 0 eng d
022 _a1520-4804
024 7 _a10.1021/jm1012819
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRadi, Marco
245 0 0 _aDesign, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
_h[electronic resource]
260 _bJournal of medicinal chemistry
_cApr 2011
300 _a2610-26 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aCell Hypoxia
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aHumans
650 0 4 _aLeukemia
_xpathology
650 0 4 _aMagnetic Resonance Spectroscopy
650 0 4 _aMass Spectrometry
650 0 4 _aModels, Molecular
650 0 4 _aPyrazoles
_xchemical synthesis
650 0 4 _aPyrimidines
_xchemical synthesis
700 1 _aDreassi, Elena
700 1 _aBrullo, Chiara
700 1 _aCrespan, Emmanuele
700 1 _aTintori, Cristina
700 1 _aBernardo, Vincenzo
700 1 _aValoti, Massimo
700 1 _aZamperini, Claudio
700 1 _aDaigl, Henry
700 1 _aMusumeci, Francesca
700 1 _aCarraro, Fabio
700 1 _aNaldini, Antonella
700 1 _aFilippi, Irene
700 1 _aMaga, Giovanni
700 1 _aSchenone, Silvia
700 1 _aBotta, Maurizio
773 0 _tJournal of medicinal chemistry
_gvol. 54
_gno. 8
_gp. 2610-26
856 4 0 _uhttps://doi.org/10.1021/jm1012819
_zAvailable from publisher's website
999 _c20712602
_d20712602